HIV-1 vaccine-induced T-cell responses cluster in epitope hotspots that differ from those induced in natural infection with HIV-1.
about
Mechanisms of HIV protein degradation into epitopes: implications for vaccine designAltered response hierarchy and increased T-cell breadth upon HIV-1 conserved element DNA vaccination in macaques.Cryopreservation-related loss of antigen-specific IFNγ producing CD4+ T-cells can skew immunogenicity data in vaccine trials: Lessons from a malaria vaccine trial substudy.Advancing Toward HIV-1 Vaccine Efficacy through the Intersections of Immune Correlates.Challenges in HIV Vaccine Research for Treatment and Prevention.Challenges in the design of a T cell vaccine in the context of HIV-1 diversity.Identification of effective subdominant anti-HIV-1 CD8+ T cells within entire post-infection and post-vaccination immune responses.Cellular immune correlates analysis of an HIV-1 preexposure prophylaxis trial.Multiple B-cell epitope vaccine induces a Staphylococcus enterotoxin B-specific IgG1 protective response against MRSA infectionVaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083Broad HIV-1 inhibition in vitro by vaccine-elicited CD8(+) T cells in African adults.Preferential Targeting of Conserved Gag Regions after Vaccination with a Heterologous DNA Prime-Modified Vaccinia Virus Ankara Boost HIV-1 Vaccine Regimen.Complex immune correlates of protection in HIV-1 vaccine efficacy trials.The value of HIV protective epitope research for informed vaccine design against diverse viral pathogensDevelopment of an epitope-based HIV-1 vaccine strategy from HIV-1 lipopeptide to dendritic-based vaccines.Immune Interventions to Eliminate the HIV Reservoir.First-in-Human Randomized Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector.
P2860
Q26866505-2AE65371-A8BA-4623-BDDA-1C84EB196E2FQ31148797-ABEEC84D-3F69-4429-9CAB-2B60773160C0Q33551527-837DFC4D-7231-496E-8351-3BC6C80433C3Q33742529-525FDD4E-412F-45D5-98BA-6BCB2C5BAD6AQ34148683-B0878DA8-15ED-44E3-A96A-703D58BC93D7Q34423446-AC03C397-06E9-4C61-849C-5A02E3BD43BEQ35130519-786912E7-5775-451E-9F7D-AAF3640CC260Q35845726-9F6A5724-C0D2-4CA8-8DD9-71DCE8BF363FQ35880774-20A1D0B6-7C98-4F36-953D-F9795EA52733Q36487887-A9710A90-2939-4C1E-8A49-67F9700113FBQ37221660-16D2BBC8-A86F-492E-8D96-416EBB7D1F0FQ38897238-2B0FF4C7-50B5-48E7-9F03-E921B307C452Q39108779-F4B0EA6B-77D1-4063-A55B-CB9941B2318FQ39169929-484C14B0-E616-46C4-B473-9C0DE94EBB39Q40054175-80C71B70-4D0E-4B75-B9C7-0A6EAAB301BEQ47600062-8874C562-04AD-4108-A2D1-B417EAF1B9F7Q52580309-C4A835FB-41F5-4D42-9399-13524D919E02
P2860
HIV-1 vaccine-induced T-cell responses cluster in epitope hotspots that differ from those induced in natural infection with HIV-1.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
HIV-1 vaccine-induced T-cell r ...... natural infection with HIV-1.
@ast
HIV-1 vaccine-induced T-cell r ...... natural infection with HIV-1.
@en
HIV-1 vaccine-induced T-cell r ...... natural infection with HIV-1.
@nl
type
label
HIV-1 vaccine-induced T-cell r ...... natural infection with HIV-1.
@ast
HIV-1 vaccine-induced T-cell r ...... natural infection with HIV-1.
@en
HIV-1 vaccine-induced T-cell r ...... natural infection with HIV-1.
@nl
prefLabel
HIV-1 vaccine-induced T-cell r ...... natural infection with HIV-1.
@ast
HIV-1 vaccine-induced T-cell r ...... natural infection with HIV-1.
@en
HIV-1 vaccine-induced T-cell r ...... natural infection with HIV-1.
@nl
P2093
P2860
P50
P1433
P1476
HIV-1 vaccine-induced T-cell r ...... natural infection with HIV-1.
@en
P2093
Danilo R Casimiro
David P Friedrich
Hasan Ahmed
Helen Horton
Michael N Robertson
Nicole Frahm
Peter Gilbert
Steven G Self
P2860
P304
P356
10.1371/JOURNAL.PPAT.1003404
P577
2013-06-20T00:00:00Z